YAP/TAZ:Yes-associated protein/Trascriptional coactivator with PDZ-binding motif
参考文献
1.
Lu Y, et al. Phase separation of TAZ compartmentalizes the
transcription machinery to promote gene expression. Nat Cell Biol. 2020;
22(4): 453-464. 2. Cai D, et al. Phase separation of YAP reorganizes genome topology for
long-term YAP target gene expression. Nat Cell Biol. 2019; 21(12):
1578-1589. 3. Song K, et al. Yes-Associated Protein in Kupffer Cells Enhances the
Production of Proinflammatory Cytokines and Promotes the Development of
Nonalcoholic Steatohepatitis. Hepatology. 2020; 72(1): 72-87. 4. Xu L, et al. SHANK2 is a frequently amplified oncogene with
evolutionarily conserved roles in regulating Hippo signaling [published
online ahead of print.Protein Cell. 2020 Jul 13. 5.
Calses PC, et al. Hippo Pathway in Cancer: Aberrant Regulation and
Therapeutic Opportunities. Trends Cancer. 2019; 5(5): 297-307. 6. Yu FX, et al. Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer. Cell. 2015; 163(4): 811-828. 7. Moya IM, et al. Hippo-YAP/TAZ signalling in organ regeneration and
regenerative medicine. Nat Rev Mol Cell Biol. 2019; 20(4): 211-226. 8. Bae SJ, et al. Activation mechanisms of the Hippo kinase signaling
cascade. Biosci Rep. 2018; 38(4): BSR20171469. Published 2018 Aug 29. 9. Del Re DP. The hippo signaling pathway: implications for heart regeneration and disease. Clin Transl Med. 2014 Dec;3(1):27.10. Sebio A, et al. Molecular Pathways: Hippo Signaling, a Critical Tumor Suppressor. Clin Cancer Res. 2015; 21(22): 5002-5007.11. Run Fan,
et al. Regulation of Hippo pathway by mitogenic growthfactors via
phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1. Proc
Natl Acad Sci U S A. 2013 Feb 12;110(7): 2569–2574.12. Ma S, et al. The Hippo Pathway: Biology and Pathophysiology. Annu Rev Biochem. 2019; 88: 577-604.13. Marcello Maugeri-Saccà, et al. The Hippo pathway in normal development and cancer. Pharmacol Ther. 2018Jun;186:60-72.14.
Boopathy GTK, et al. Role of Hippo Pathway-YAP/TAZ Signaling in
Angiogenesis. Front Cell Dev Biol. 2019; 7: 49. Published 2019 Apr 10. 15. Yu FX, et al. The Hippo pathway: regulators and regulations. Genes Dev. 2013; 27(4): 355-371. 16. Kim MK, et al. DNA binding partners of YAP/TAZ. BMB Rep. 2018; 51(3): 126-133. 17. Zanconato F, et al. YAP/TAZ at the Roots of Cancer. Cancer Cell. 2016; 29(6): 783-803. 18. Dey A, et al. Targeting the Hippo pathway in cancer, fibrosis, wound
healing and regenerative medicine. Nat Rev Drug Discov. 2020; 19(7):
480-494. 19. DeRan M, et al. Energy stress regulates hippo-YAP signaling
involving AMPK-mediated regulation of angiomotin-like 1 protein. Cell
Rep. 2014; 9(2): 495-503. 20. Pobbati AV, et al. A combat with the YAP/TAZ-TEAD oncoproteins for cancer therapy. Theranostics. 2020; 10(8): 3622-3635.